BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32310088)

  • 21. Development and characteristics of the HANARO neutron irradiation facility for applications in the boron neutron capture therapy field.
    Kim MS; Lee BC; Hwang SY; Kim H; Jun BJ
    Phys Med Biol; 2007 May; 52(9):2553-66. PubMed ID: 17440252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phantom materials for boron neutron capture therapy.
    Raaijmakers CP; Nottelman EL; Mijnheer BJ
    Phys Med Biol; 2000 Aug; 45(8):2353-61. PubMed ID: 10958199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality control and quality assurance procedures at the THOR BNCT facility.
    Liu YH; Tsai PE; Lin YC; Huang CK; Liu HM; Jiang SH
    Appl Radiat Isot; 2011 Dec; 69(12):1897-900. PubMed ID: 21605978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical considerations for TLD-400/700-based gamma ray dosimetry for BNCT applications in a high thermal neutron fluence.
    Martsolf SW; Johnson JE; Vostmyer CE; Albertson BD; Binney SE
    Health Phys; 1995 Dec; 69(6):966-70. PubMed ID: 7493815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a method based on TLD detectors for in-phantom dosimetry in BNCT.
    Gambarini G; Klamert V; Agosteo S; Birattari C; Gay S; Rosi G; Scolari L
    Radiat Prot Dosimetry; 2004; 110(1-4):631-6. PubMed ID: 15353721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-line reconstruction of low boron concentrations by in vivo gamma-ray spectroscopy for BNCT.
    Verbakel WF; Stecher-Rasmussen F
    Phys Med Biol; 2001 Mar; 46(3):687-701. PubMed ID: 11277217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
    Matsuya Y; Fukunaga H; Omura M; Date H
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.
    Wang LW; Liu YH; Chou FI; Jiang SH
    Cancer Commun (Lond); 2018 Jun; 38(1):37. PubMed ID: 29914577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies.
    Schmitz T; Blaickner M; Ziegner M; Bassler N; Grunewald C; Kratz JV; Schütz C; Langguth P; Sharpe P; Palmans H; Holzscheiter MH; Otto G; Hampel G
    Acta Oncol; 2011 Aug; 50(6):817-22. PubMed ID: 21767179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and performance of an epithermal neutron flux detector using
    Guan X; Gong Y; Murata I; Wang T
    Appl Radiat Isot; 2021 Oct; 176():109880. PubMed ID: 34365204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis on the emission and potential application of Cherenkov radiation in boron neutron capture therapy: A Monte Carlo simulation study.
    Shu DY; Geng CR; Tang XB; Gong CH; Shao WC; Ai Y
    Appl Radiat Isot; 2018 Jul; 137():219-224. PubMed ID: 29655128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple ionization chamber method for clinical dose monitoring with a Be-covered Li BNCT field.
    Nguyen TT; Kajimoto T; Tanaka K; Nguyen CC; Endo S
    Med Phys; 2016 Nov; 43(11):6049. PubMed ID: 27806584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
    Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose evaluation of boron neutron capture synovectomy using the THOR epithermal neutron beam: a feasibility study.
    Wu J; Chang SJ; Chuang KS; Hsueh YW; Yeh KC; Wang JN; Tsai WP
    Phys Med Biol; 2007 Mar; 52(6):1747-56. PubMed ID: 17327660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
    Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
    Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetry of the boron neutron capture reaction for BNCT and BNCEFNT.
    Burmeister J; Kota C; Maughan RL
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():115-8. PubMed ID: 10394417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microdosimetric spectra of the THOR neutron beam for boron neutron capture therapy.
    Hsu FY; Tung CJ; Watt DE
    Radiat Prot Dosimetry; 2003; 104(2):121-6. PubMed ID: 12918789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of low-pressure tissue equivalent proportional counters for the dosimetry of neutron beams used in BNCT and BNCEFNT.
    Kota C; Maughan RL; Tattam D; Beynon TD
    Med Phys; 2000 Mar; 27(3):535-48. PubMed ID: 10757605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prompt gamma and neutron detection in BNCT utilizing a CdTe detector.
    Winkler A; Koivunoro H; Reijonen V; Auterinen I; Savolainen S
    Appl Radiat Isot; 2015 Dec; 106():139-44. PubMed ID: 26249745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of dose planning calculations for boron neutron capture therapy using cylindrical and anthropomorphic phantoms.
    Koivunoro H; Seppälä T; Uusi-Simola J; Merimaa K; Kotiluoto P; Serén T; Kortesniemi M; Auterinen I; Savolainen S
    Phys Med Biol; 2010 Jun; 55(12):3515-33. PubMed ID: 20508317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.